Lyrica reclassified after being linked to 33 deaths
The drug was linked to 33 deaths in in Northern Ireland in 2018, a jump from just eight in 2017.
Read More
Tag: pregabalin
Pfizer loses landmark second medical use patent case
The UK Supreme Court has ruled against Pfizer in a long-running legal battle over the validity of a second medical use patent protecting pregabalin.
Read More
NHS could claw back £502m if Lyrica ruling upheld, study finds
The NHS could reclaim up to £502 million in excess prescribing costs relating to Pfizer’s pregabalin if the drug giant’s last effort to uphold the drug’s legal protection is unsuccessful, a study has found.
Read More
December CHMP decisions bring year’s total approvals to 81
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has backed seven new medicines for approval at its December meeting, bringing the total number recommended during the year to 81, dropping from 2015’s tally of 93.
Read More
Pfizer loses second medical use patent case
Pfizer says it is disappointed with a UK Court of Appeal ruling backing an earlier judgement that its patent protecting pregabalin for pain has not been infringed by Actavis.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
